Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Application of tannic acid to preparation of cardiac hypertrophy antagonist

A technology for myocardial hypertrophy and tannic acid, which can be applied in drug combinations, pharmaceutical formulas, cardiovascular system diseases, etc., and can solve problems such as incomplete elucidation of pathogenesis

Inactive Publication Date: 2017-02-08
HEBEI UNIV OF CHINESE MEDICINE
View PDF0 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Cardiac hypertrophy is an adaptive response of cardiomyocytes to a variety of stimuli. It is a complex pathological process, and its pathogenesis has not yet been fully elucidated.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of tannic acid to preparation of cardiac hypertrophy antagonist
  • Application of tannic acid to preparation of cardiac hypertrophy antagonist
  • Application of tannic acid to preparation of cardiac hypertrophy antagonist

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0067] Embodiment 1 Tannic acid anti-myocardial hypertrophy effect caused by abdominal aorta ligation

[0068] 1.1 Experimental animals

[0069] 40 purebred clean-grade SD rats, weighing 200-240 g, were purchased from the Experimental Animal Center of Hebei Medical University.

[0070] 1.2 Experimental Drugs

[0071] Tannic acid (TA) was purchased from Sigma Chemicals (St. Louis, MO, USA).

[0072] Captoril (CAP) was purchased from Huanghai Pharmaceutical Company (Shanghai, China).

[0073] 1.3 Experimental method

[0074] Rats were randomly divided into 5 groups: sham operation group (Sham), abdominal aortic ligation model control group (abdominal ortic banding, AAB), TA low-dose group (20mg / kg, L-TA), TA high-dose group (40mg / kg kg, H-TA), captopril group (30mg / kg, CAP), 8 rats in each group.

[0075] Except the Sham group, the rats in other groups were anesthetized by intraperitoneal injection of 20g / L pentobarbital 40mg / kg, the abdominal cavity was opened, and the abd...

Embodiment 2

[0096] Embodiment 2 prepares oral tablet

[0097] Tablets are prepared according to methods known in the art, each containing the following ingredients:

[0098]

[0099] Table 1 Effect of tannic acid on hemodynamics in rats with abdominal aorta ligation

[0100]

[0101] Table 2 Effect of tannic acid on heart weight index of rats with abdominal aorta ligation

[0102]

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

An application of tannic acid to preparation of a cardiac hypertrophy antagonist relates to the medical application of tannic acid. Disclosed are an application of tannic acid to preparation of a cardiac hypertrophy antagonist, an application of tannic acid to preparation of anti-oxidative stress, multiple-target-point inflammation inhibition, fibrosis apoptosis drugs, and especially an application aiming at cardiac hypertrophy due to ligation of aorta abdominalis. An application of tannic acid, which is a polyphenol compound, is developed.

Description

technical field [0001] The invention relates to the medical use of tannic acid, in particular to the application of tannic acid to antagonize myocardial hypertrophy. Background technique [0002] Tannic acid, also known as tannic acid (tannic acid), is a class of polyphenolic compounds with complex structures widely present in the plant kingdom. More than 70% of crude drugs contain tannin compounds, such as Salicaceae, Fabaceae, Polygonaceae, Rubiaceae and Beech in gymnosperms and dicotyledonous plants. Tannin exists in the bark, wood, leaves, roots, fruits and other parts of plants, and is most common in bark. The relatively high levels of tannins in red wine (grape) and green tea are believed to be key to their beneficial health effects. [0003] Cardiac hypertrophy is a compensatory response of the heart to maintain proper contractile function, manifested as cardiomyocyte hypertrophy, collagen hyperplasia, abnormal increase in heart weight, and myocardial remodeling. M...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K31/7024A61P9/00
CPCA61K31/7024A61K2300/00
Inventor 张建平李品雅楚立张园园宋琼涛
Owner HEBEI UNIV OF CHINESE MEDICINE
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com